These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17408400)

  • 1. Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas.
    Lee JJ; Kim DH; Lee NY; Sohn SK; Kim JG; Kim HJ; Do YR; Park YH
    Br J Haematol; 2007 May; 137(4):329-36. PubMed ID: 17408400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
    Kube D; Hua TD; von Bonin F; Schoof N; Zeynalova S; Klöss M; Gocht D; Potthoff B; Tzvetkov M; Brockmöller J; Löffler M; Pfreundschuh M; Trümper L
    Clin Cancer Res; 2008 Jun; 14(12):3777-84. PubMed ID: 18559596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy.
    Park YH; Sohn SK; Kim JG; Lee MH; Song HS; Kim MK; Jung JS; Lee JJ; Kim HJ; Kim DH
    Clin Cancer Res; 2009 Mar; 15(6):2107-15. PubMed ID: 19276283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective analysis of treatment outcome and prognostic factors in patients with T-cell lymphomas treated by CEOP-B: single institutional study.
    Sung HJ; Kim SJ; Seo HY; Sul HR; Choi JG; Choi IK; Park KH; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
    Br J Haematol; 2006 Jul; 134(1):45-53. PubMed ID: 16803566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation.
    Seo KW; Kim DH; Sohn SK; Lee NY; Chang HH; Kim SW; Jeon SB; Baek JH; Kim JG; Suh JS; Lee KB
    Bone Marrow Transplant; 2005 Dec; 36(12):1089-95. PubMed ID: 16247433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkin's lymphoma.
    Møller MB; Gerdes AM; Skjødt K; Mortensen LS; Pedersen NT
    Clin Cancer Res; 1999 May; 5(5):1085-91. PubMed ID: 10353742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma.
    Fernberg P; Chang ET; Duvefelt K; Hjalgrim H; Eloranta S; Sørensen KM; Porwit A; Humphreys K; Melbye M; Ekström Smedby K
    Cancer Causes Control; 2010 May; 21(5):759-69. PubMed ID: 20087644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of interleukin-10 polymorphisms (-1082 and -3575) on the survival of patients with lymphoid neoplasms.
    Domingo-Domènech E; Benavente Y; González-Barca E; Montalban C; Gumà J; Bosch R; Wang SS; Lan Q; Whitby D; Fernández de Sevilla A; Rothman N; de Sanjosé S
    Haematologica; 2007 Nov; 92(11):1475-81. PubMed ID: 18024395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95.
    Seidemann K; Zimmermann M; Book M; Meyer U; Burkhardt B; Welte K; Reiter A; Stanulla M
    J Clin Oncol; 2005 Nov; 23(33):8414-21. PubMed ID: 16293872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis.
    Wieczorek S; Hellmich B; Arning L; Moosig F; Lamprecht P; Gross WL; Epplen JT
    Arthritis Rheum; 2008 Jun; 58(6):1839-48. PubMed ID: 18512809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgkin lymphoma.
    Sakata K; Satoh M; Someya M; Asanuma H; Nagakura H; Oouchi A; Nakata K; Kogawa K; Koito K; Hareyama M; Himi T
    Cancer; 2004 Jan; 100(2):356-65. PubMed ID: 14716772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma.
    Kim HN; Lee IK; Kim YK; Tran HT; Yang DH; Lee JJ; Shin MH; Park KS; Shin MG; Choi JS; Kim HJ
    Br J Haematol; 2008 Feb; 140(3):287-94. PubMed ID: 18042267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The polymorphisms of interleukin-10 gene influence the prognosis of patients with advanced melanoma.
    Vuoristo MS
    Cancer Genet Cytogenet; 2007 Jul; 176(1):54-7. PubMed ID: 17574964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
    Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
    J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-10 haplotype associated with total serum IgE in atopic dermatitis patients.
    Shin HD; Park BL; Kim LH; Kim JS; Kim JW
    Allergy; 2005 Sep; 60(9):1146-51. PubMed ID: 16076299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of TNF receptor II are prognostic for patients with peripheral T-cell non-Hodgkin lymphoma.
    Heemann C; Kreuz M; Stoller I; Schoof N; von Bonin F; Ziepert M; Löffler M; Jung W; Pfreundschuh M; Trümper L; Kube D
    Clin Cancer Res; 2012 Jul; 18(13):3637-47. PubMed ID: 22573350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FcgammaRIIa polymorphism and clinical response to rituximab in non-Hodgkin lymphoma patients.
    Paiva M; Marques H; Martins A; Ferreira P; Catarino R; Medeiros R
    Cancer Genet Cytogenet; 2008 May; 183(1):35-40. PubMed ID: 18474295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-10 gene polymorphisms influence the clinical course of non-Hodgkin's lymphoma.
    Bogunia-Kubik K; Mazur G; Wróbel T; Kuliczkowski K; Lange A
    Tissue Antigens; 2008 Feb; 71(2):146-50. PubMed ID: 18201362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
    Nyman H; Jerkeman M; Karjalainen-Lindsberg ML; Banham AH; Enblad G; Leppä S
    Eur J Haematol; 2009 May; 82(5):364-72. PubMed ID: 19141121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta1 gene polymorphisms influence the course of the disease in non-Hodgkin's lymphoma patients.
    Mazur G; Bogunia-Kubik K; Wrobel T; Kuliczkowski K; Lange A
    Cytokine; 2006 Feb; 33(3):145-9. PubMed ID: 16524740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.